AMS files patent lawsuit against BI in Colorado’s Federal government District Court Denver-based Alcohol Monitoring Systems filed suit today in Colorado’s Federal government District Court asserting that Boulder-based BI Integrated, a pending acquisition of The GEO Group, offers infringed multiple patents with their BI TAD system. The GEO Group is among the nation’s largest operators of correctional services ed pills . According to AMS Chairman and CEO Mike Iiams, his company made the decision to document the match after multiple attempts to utilize BI executives and resolve the infringement problems. We made every attempt to resolve the problem without litigation.
Reducing sIGF-I levels is the major marker of ATL1103 activity in this trial as acromegaly individuals have elevated sIGF-I amounts compared to the normal population and moreover, reduced amount of sIGF-I to within the standard range in a significant proportion of patients may be the goal in Stage III sign up trials for acromegaly remedies. Results In the 4 individuals who received the 400 mg per week dose, ATL1103 reduced sIGF-I levels regularly and by the average of 30 percent at week 14 which is the primary efficacy time point for the trial.